Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact
Search
Close
Enter Search Terms
Search
Daniel Daniele (CA)
ID:
1b837935-2619-30fb-68c4
/
Claimed Record
/
Organization:
Norton Rose Fulbright
Published Works
11 articles
First trial judgment under new PMNOC Regulations declares claims to biologic drug invalid
Pharma in Brief ·
April 21, 2020
cite
Patent owner files its own pleading in a PM(NOC) action
Pharma in Brief ·
January 29, 2020
cite
Stockpiling generic manufacturers may be liable for direct infringement of “composition for a use” claims
Pharma in Brief ·
November 7, 2019
cite
Health Canada publishes new amendments to the Food and Drug Regulations and Medical Devices Regulations allowing for public release of clinical information in regulatory submissions
Pharma in Brief ·
March 25, 2019
cite
Health Canada rejects product-specific suffixes for biosimilars in favour of unique brand names
Pharma in Brief ·
February 24, 2019
cite
Previous
1
2
3
Next
Practice Areas
Privacy and Cybersecurity
Health Care and Life Sciences
Jurisdictions
North America
United States
Canada
